https://www.selleckchem.com/pr....oducts/k-ras-g12c-in
8%) and placebo groups (62.5%) (χ = 4.20, p = 0.04). Adjunct therapy with Yimingjia was safe and effective at 4weeks in the treatment of chronic urticaria in children. The study was registered under trial number NCT03328897. Adjunct therapy with Yimingjia® was safe and effective at 4 weeks in the treatment of chronic urticaria in children. The study was registered under trial number NCT03328897.Nowadays, a potent challenge in cancer treatment is considered the lack of efficacious strategy, which has not been able to signi
Like
Comment
Share
